The Distribution of Pharmaceutical Demand Across Therapeutic Categories Offers an Important Signal for International Manufacturers Looking at Bangladesh

Before asking “Can we enter Bangladesh?”, perhaps the better question is: “Where should we compete?”

Bangladesh is an increasingly important pharmaceutical market. But for an international manufacturer, knowing the overall market size is only the beginning.

The more practical question is: Which therapeutic categories are creating the strongest opportunities?

Looking at the distribution of pharmaceutical demand across therapeutic categories can provide an important starting point for answering that question.

🔎 Step 1 — Don't look at the market as one big number

A pharmaceutical market is not one market. It is a collection of different therapeutic segments — each with its own:

  • Patient demand
  • Prescribing patterns
  • Competition
  • Local manufacturing capability
  • Regulatory requirements
  • Pricing dynamics
  • Product availability
That means an international manufacturer should not necessarily approach Bangladesh with its entire product portfolio at once. Instead, the first step should be: Identify where the demand is concentrated.

📊 Step 2 — What does the therapeutic-category distribution tell us?

The chart below provides a snapshot of the distribution across major therapeutic categories.

Therapeutic-category distribution
Therapeutic-category distribution

Gastrointestinal & Metabolism represents the largest segment in the dataset shown, followed by Cardiovascular & Blood and Anti-Infectives. Dermatological & Topical Care and Nervous System & CNS also represent meaningful therapeutic areas.

But there is an important point here: A larger category does not automatically mean an easier market. It means there may be a larger pool of demand to investigate. The real commercial opportunity depends on what comes next.

🧩 Step 3 — Turn a therapeutic category into a business opportunity

This is where market analysis becomes useful. Suppose an international manufacturer identifies Cardiovascular & Blood as an attractive therapeutic area. The analysis should not stop there. Instead, the manufacturer can move through a simple process:

Therapeutic Category
↓
Relevant Molecules / Products
↓
Local Market Demand
↓
Existing Competitors
↓
Local Manufacturers / Potential Customers
↓
Regulatory & Registration Requirements
↓
Price & Commercial Feasibility
↓
Market Entry Decision

This is much more useful than simply saying: “Cardiovascular is a large category.”

🎯 Step 4 — Look at the category from the manufacturer's perspective

For an international API, intermediate, excipient or specialty-chemical manufacturer, the question becomes slightly different.

Instead of asking: “Which products can we export to Bangladesh?”
Ask: “Which products within our portfolio support attractive therapeutic segments in Bangladesh?”

That small change in thinking can completely change the market-development strategy. For example:

Therapeutic Area → Molecule → Local formulation manufacturers → Potential customers → Registration → Commercial opportunity

Now the market data becomes a product-selection tool, rather than just a statistic.

⚠️ Step 5 — Don't confuse market size with market opportunity

This is one of the most important points.

A large therapeutic category can have:
High demand + very strong competition + aggressive pricing
while a smaller category could have:
Moderate demand + limited competition + better product differentiation

Therefore: The largest segment is not always the best segment. International manufacturers should evaluate at least four dimensions:

1️⃣
Demand

Is the market actually consuming the product/category?

2️⃣
Competition

How many local and international suppliers are already active?

3️⃣
Differentiation

Does the manufacturer offer something commercially valuable?

4️⃣
Feasibility

Can the product be registered, supplied and priced competitively?

🌏 Step 6 — What should international manufacturers do?

Rather than entering Bangladesh with a broad portfolio and approaching customers randomly, a more structured approach could be:

1. Map the therapeutic categories
↓
2. Identify attractive molecules/products
↓
3. Study local manufacturers and competitors
↓
4. Evaluate regulatory requirements
↓
5. Compare price and supply feasibility
↓
6. Prioritize the most promising opportunities
↓
7. Develop the right local commercial strategy

This turns market entry into a process rather than a guess.

💡 The bigger lesson

Therapeutic-category data doesn't tell a manufacturer exactly what to sell. What it does is help answer a much more important question: “Where should we look first?”

And that is often the starting point for a much deeper market-development exercise.

For international pharmaceutical manufacturers, successful entry into Bangladesh may therefore depend not only on having a competitive product — but on choosing the right therapeutic segment, the right molecules and the right local commercial strategy.

One final question for international manufacturers

If you were evaluating Bangladesh today, would you start by looking at the total market size — or by identifying the therapeutic categories where your portfolio has the strongest potential?